Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hui-Sheng Ai

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Zhongguo Shi Yan Xue Ye Xue Za Zhi|November 14, 2006
[Cloning and expression of HLA-A*0201-BSP]Wan-Jun Sun, Jian-Fang DU, Dong-Gang Xu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|May 12, 2007
[Construction and characterization of soluble HLA-A*0201-PR1 complex]Wan-Jun Sun, Dong-Gang Xu, Hai-Lan Hu, et al.
Transplantation and Cellular Therapy|March 21, 2023
Mechanisms of Thymic Repair of In Vitro-Induced Precursor T Cells as a Haploidentical Hematopoietic Stem Cell Transplantation RegimenYang-Yang Lei, Xin-Rui Chen, Shan Jiang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|December 25, 2009
[Changes of lymphocyte subsets in acute leukemia patients after HLA-mismatched nonmyeloablative hematopoietic stem cell transplantation]Kai-Xun Hu, Mei Guo, Chang-Lin Yu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 4, 2009
[Multicenter report of nonmyeloablative allogeneic stem cell transplantation for hematologic diseases]Hui-sheng Ai, Xiao-jun Huang, Zhen-hua Qiao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 4, 2003
[Comparison of conditioning regimens containing or no fludarabine in nonmyeloablative allogeneic peripheral blood stem cell transplantation]Mei Guo, Chang-lin Yu, Dan-hong Wang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 18, 2015
[Clinical efficacy of switching to 2nd generation of tyrosine kinase inhibitor on CML patients at poor responses to imatinib]Jian-Hui Qiao, Ze-Chuan Zhang, Bo Yao, et al.
Zhonghua Yi Xue Za Zhi|June 19, 2003
[Clinical significance of formation and conversion of hematopoietic mixed chimerism in nonmyeloablative allogeneic stem cell transplantation]Hui-sheng Ai, Chang-lin Yu, Dan-hong Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 28, 2005
[Establishment of a rhesus haploidentical hematopoietic stem cell and mesenchymal stem cell transplantation model by nonmyeloablative conditioning]Li-hui Liu, Qi-yun Sun, Kai-xun Hu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 17, 2003
[The clinical research of nonmyeloablative allogeneic peripheral blood hematopoietic stem cells transplantation for hematological diseases]Hui-sheng Ai, Chang-lin Yu, Dan-hong Wang, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Zhongguo Shi Yan Xue Ye Xue Za Zhi|November 14, 2006
[Cloning and expression of HLA-A*0201-BSP]Wan-Jun Sun, Jian-Fang DU, Dong-Gang Xu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|May 12, 2007
[Construction and characterization of soluble HLA-A*0201-PR1 complex]Wan-Jun Sun, Dong-Gang Xu, Hai-Lan Hu, et al.
Transplantation and Cellular Therapy|March 21, 2023
Mechanisms of Thymic Repair of In Vitro-Induced Precursor T Cells as a Haploidentical Hematopoietic Stem Cell Transplantation RegimenYang-Yang Lei, Xin-Rui Chen, Shan Jiang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|December 25, 2009
[Changes of lymphocyte subsets in acute leukemia patients after HLA-mismatched nonmyeloablative hematopoietic stem cell transplantation]Kai-Xun Hu, Mei Guo, Chang-Lin Yu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 4, 2009
[Multicenter report of nonmyeloablative allogeneic stem cell transplantation for hematologic diseases]Hui-sheng Ai, Xiao-jun Huang, Zhen-hua Qiao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 4, 2003
[Comparison of conditioning regimens containing or no fludarabine in nonmyeloablative allogeneic peripheral blood stem cell transplantation]Mei Guo, Chang-lin Yu, Dan-hong Wang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 18, 2015
[Clinical efficacy of switching to 2nd generation of tyrosine kinase inhibitor on CML patients at poor responses to imatinib]Jian-Hui Qiao, Ze-Chuan Zhang, Bo Yao, et al.
Zhonghua Yi Xue Za Zhi|June 19, 2003
[Clinical significance of formation and conversion of hematopoietic mixed chimerism in nonmyeloablative allogeneic stem cell transplantation]Hui-sheng Ai, Chang-lin Yu, Dan-hong Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 28, 2005
[Establishment of a rhesus haploidentical hematopoietic stem cell and mesenchymal stem cell transplantation model by nonmyeloablative conditioning]Li-hui Liu, Qi-yun Sun, Kai-xun Hu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 17, 2003
[The clinical research of nonmyeloablative allogeneic peripheral blood hematopoietic stem cells transplantation for hematological diseases]Hui-sheng Ai, Chang-lin Yu, Dan-hong Wang, et al.
Pageof 8